| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.48B | 46.75B | 44.73B | 49.05B | 44.80B | 34.11B |
| Gross Profit | 7.52B | 7.96B | 6.91B | 7.42B | 7.63B | 5.33B |
| EBITDA | 5.55B | 6.27B | 5.23B | 5.78B | 6.18B | 3.91B |
| Net Income | 2.74B | 3.25B | 2.59B | 3.09B | 3.18B | 1.83B |
Balance Sheet | ||||||
| Total Assets | 55.70B | 56.10B | 53.61B | 54.25B | 51.41B | 46.17B |
| Cash, Cash Equivalents and Short-Term Investments | 16.63B | 17.07B | 15.24B | 14.66B | 15.64B | 13.78B |
| Total Debt | 324.00M | 272.00M | 460.00M | 671.00M | 380.00M | 644.00M |
| Total Liabilities | 14.41B | 14.19B | 14.12B | 16.64B | 15.96B | 13.19B |
| Stockholders Equity | 40.60B | 41.21B | 38.89B | 37.05B | 34.96B | 32.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.30B | 2.04B | -95.00M | 2.76B | 2.48B |
| Operating Cash Flow | 0.00 | 4.72B | 4.68B | 1.86B | 4.47B | 3.96B |
| Investing Cash Flow | 0.00 | -1.34B | -2.82B | -1.78B | -1.70B | -1.79B |
| Financing Cash Flow | 0.00 | -1.71B | -1.54B | -1.05B | -1.34B | -702.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.83B | 13.22 | ― | 3.89% | 1.33% | 29.73% | |
77 Outperform | ¥28.44B | 11.97 | ― | 2.76% | 7.69% | -0.40% | |
77 Outperform | ¥20.97B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
74 Outperform | ¥47.22B | 14.09 | ― | 3.70% | -1.05% | -14.70% | |
73 Outperform | ¥13.34B | 44.98 | ― | 3.84% | 5.57% | 89.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥7.17B | 8.05 | 3.72% | 1.17% | 7.68% | ― |